SCHWARTZ BRIAN 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Dec 21, 2020
Insider Transaction Report
Form 4
SCHWARTZ BRIAN
Director
Transactions
- Award
Stock Option (right to buy)
2020-12-17+5,200→ 5,200 totalExercise: $4.13From: 2021-12-17Exp: 2030-12-17→ Common Stock (5,200 underlying)
Footnotes (1)
- [F1]These options were granted to Dr. Schwartz for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.